All articles by Vemula Pravalika
Vemula Pravalika
Growing demand for monitoring systems: Two non-invasive patient monitoring experts establish a commercial partnership to co-promote technologies
Nonin Medical, a leading provider of SpO2 monitoring solutions and Corscience, a leading provider of CO2 monitoring solution have entered into a partnership to co-promote each other’s OEM product offerings. The two experienced manufacturers are collaborating to better serve both the US and European markets with the highest quality patient monitoring offerings.
MEDICA and COMPAMED 2024: Optimized Layout Enhances Visitor Experience
The upcoming MEDICA and COMPAMED 2024 trade fairs in Düsseldorf are set to showcase the latest innovations in medical technology and healthcare. With over 6,000 exhibitors from 70 countries, the events will occupy the entire exhibition grounds from November 11-14, 2024.
Seegene Showcased its Multiplex Technology at ADLM 2024
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, showcased its key products and systems at the Association for Diagnostics & Laboratory Medicine 2024 (ADLM 2024) under the exhibition theme “One Sample, Many Answers.” The event was held in Chicago from July 30 to August 1.
Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices
Abbott (NYSE: ABT) today announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott’s most advanced, world-leading1 FreeStyle Libre technology that will connect with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems.
Complete IFA automation on one device
The UNIQO 160 is an all-in-one device for complete automation of indirect immunofluorescence assays (IFA) from primary sample to result proposal. The newly incorporated EUROPattern Classifier from EUROIMMUN provides AI-based evaluation of ANA, ANCA, CLIFT, as well as various autoantibodies on tissues and transfected-cell substrates.
V-Veil UP2 for HPV and STDs easy detection
Considering cervical cancer is one of the most common forms of cancers in women, V-Veil-Up Production meets the WHO’s request for early detection, and offers a self-sampling vaginal veil for HPV and STDs detection
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available
Bosch Healthcare Solutions has introduced a new PCR test for C. difficile, norovirus, and rotavirus, expanding the Vivalytic analysis platform’s capabilities to include gastroenteritis. This innovative test can simultaneously and automatically detect these 3 major diarrhea pathogens in under an hour right on site. Unlike previous tests that either included these pathogens in a larger panel or tested for each individually, this triple test is the first of its kind. The new Vivalytic test is available through distribution partners such as Randox Laboratories and R-Biopharm. “We developed this test so that medical practices and clinics can identify the cause of gastroenteritis more quickly and respond appropriately: with the right treatment and measures to prevent further spread and infection,” explains Marc Meier, president of Bosch Healthcare Solutions. Due to transportation and limited test availability, the complete detection of C. difficile can take up to several days.
Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of Shield Spiral, an extension of the Kerecis Shield silicon fish-skin combination product range.
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis (TB) infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus (QFT-Plus).
bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).